Search
Now showing items 1-6 of 6
Personalized management of dyslipidemias in patients with diabetes-it is time for a new approach (2022)
(2022)
Abstract:
Dyslipidemia in patients with type 2 diabetes (DMT2) is one of the worst controlled worldwide, with only about 1/4 of patients being on the low-density lipoprotein cholesterol (LDL-C) target. There are many ...
Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health
(2022)
Abstract:
Obesity, type 2 diabetes (T2DM), hypertension (HTN), and Cardiovascular Disease (CVD) often cluster together as “Cardiometabolic Disease” (CMD). Just under 50% of patients with CMD increased the risk of morbidity ...
Incidence of gestational diabetes mellitus in the United Arab Emirates; comparison of six diagnostic criteria: The Mutaba'ah Study
(2022-12)
Background:
For more than half a century, there has been much research and controversies on how to accurately screen for and diagnose gestational diabetes mellitus (GDM). There is a paucity of updated research among the ...
Metabolic Syndrome in Fasting and Non-Fasting Participants: The UAE Healthy Future Study
(2022)
Abstract:
Metabolic syndrome (MetS) is a multiplex of risk factors that predispose people to the development of diabetes and cardiovascular disease (CVD), two of the major noncommunicable diseases that contribute to ...
Disease-Associated Regulation of Non-Coding RNAs by Resveratrol: Molecular Insights and Therapeutic Applications
(2022-07)
Abstract:
There have been significant advances, particularly over the last 20 years, in the identification of non-coding RNAs (ncRNAs) and their pathophysiological role in a wide range of disease states, particularly ...
Polycystic Ovarian Syndrome (PCOS): Does the Challenge End at Conception?
(2022)
Abstract:
Polycystic ovary syndrome (PCOS) is a prevalent condition that not only has the potential to impede conception but also represents the most common endocrine dysfunction in fertile women. It is considered a ...